Barclays PLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$144.95 - $152.29 $15.6 Million - $16.3 Million
107,352 Added 96.94%
218,095 $33 Million
Q2 2022

Aug 12, 2022
BUY
$83.14 - $145.99 $8.41 Million - $14.8 Million
101,146 Added 1053.93%
110,743 $16.1 Million
Q1 2022

May 16, 2022
SELL
$110.08 - $142.92 $6.39 Million - $8.29 Million
-58,008 Reduced 85.8%
9,597 $1.14 Million
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $4.46 Million - $6.65 Million
44,756 Added 195.88%
67,605 $9.32 Million
Q3 2021

Nov 09, 2021
BUY
$98.85 - $138.91 $1.42 Million - $1.99 Million
14,335 Added 168.37%
22,849 $3.17 Million
Q2 2021

Aug 13, 2021
SELL
$65.78 - $105.02 $2.09 Million - $3.33 Million
-31,734 Reduced 78.85%
8,514 $826,000
Q1 2021

May 13, 2021
SELL
$64.07 - $91.75 $5.09 Million - $7.28 Million
-79,389 Reduced 66.36%
40,248 $2.75 Million
Q4 2020

Feb 11, 2021
BUY
$65.07 - $98.24 $6.34 Million - $9.57 Million
97,454 Added 439.32%
119,637 $10.3 Million
Q3 2020

Nov 12, 2020
SELL
$59.04 - $77.95 $529,057 - $698,509
-8,961 Reduced 28.77%
22,183 $1.44 Million
Q2 2020

Aug 12, 2020
SELL
$29.01 - $74.23 $4.88 Million - $12.5 Million
-168,260 Reduced 84.38%
31,144 $2.28 Million
Q1 2020

May 13, 2020
BUY
$27.51 - $57.29 $256,145 - $533,427
9,311 Added 4.9%
199,404 $6.79 Million
Q4 2019

Feb 10, 2020
BUY
$40.86 - $57.65 $6.98 Million - $9.85 Million
170,812 Added 885.91%
190,093 $10.3 Million
Q3 2019

Nov 14, 2019
SELL
$37.38 - $49.47 $126,755 - $167,752
-3,391 Reduced 14.96%
19,281 $804,000
Q2 2019

Aug 14, 2019
SELL
$39.79 - $67.01 $1.71 Million - $2.87 Million
-42,873 Reduced 65.41%
22,672 $993,000
Q1 2019

May 15, 2019
BUY
$34.52 - $53.29 $2.25 Million - $3.48 Million
65,222 Added 20192.57%
65,545 $3.37 Million
Q4 2018

Feb 14, 2019
SELL
$29.75 - $42.9 $380,324 - $548,433
-12,784 Reduced 97.54%
323 $12,000
Q3 2018

Nov 14, 2018
BUY
$32.79 - $43.0 $54,464 - $71,423
1,661 Added 14.51%
13,107 $492,000
Q2 2018

Aug 14, 2018
SELL
$23.62 - $42.29 $838,628 - $1.5 Million
-35,505 Reduced 75.62%
11,446 $452,000
Q1 2018

May 15, 2018
BUY
$22.49 - $34.56 $984,342 - $1.51 Million
43,768 Added 1375.05%
46,951 $1.21 Million
Q4 2017

Feb 14, 2018
BUY
$20.44 - $35.56 $35,586 - $61,909
1,741 Added 120.74%
3,183 $86,000
Q3 2017

Nov 14, 2017
BUY
$23.54 - $38.21 $33,944 - $55,098
1,442
1,442 $54,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email